
Azeloprazole
CAS No. 955095-45-1
Azeloprazole( E-3710 | Z-215 )
Catalog No. M16817 CAS No. 955095-45-1
A novel potent proton pump inhibitor that irreversibly inhibits H+,K+-ATPase activity with IC50 of 0.28 uM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
![]() ![]() |
50MG | 1782 | Get Quote |
![]() ![]() |
100MG | 2250 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameAzeloprazole
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel potent proton pump inhibitor that irreversibly inhibits H+,K+-ATPase activity with IC50 of 0.28 uM.
-
DescriptionA novel potent proton pump inhibitor that irreversibly inhibits H+,K+-ATPase activity with IC50 of 0.28 uM; inhibits histamine-stimulated gastric acid secretion with ED50 of 0.18-0.2 mg/kg in gastric fistula model in dogs, displays 2.3-fold more potency over Esomeprazole.Other Indication Phase 1 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsE-3710 | Z-215
-
PathwayMembrane Transporter/Ion Channel
-
TargetProton Pump
-
RecptorProton Pump
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number955095-45-1
-
Formula Weight429.535
-
Molecular FormulaC22H27N3O4S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC1=CN=C(C(=C1OCC2COC(OC2)(C)C)C)CS(=O)C3=NC4=CC=CC=C4N3
-
Chemical Name(R)-2-(((4-((2,2-Dimethyl-1,3-dioxan-5-yl)methoxy)-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzimidazole
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kodama K, et al. J Pharmacol Exp Ther. 2010 Aug;334(2):395-401.
2. Toda R, et al. J Clin Pharmacol. 2017 Nov 28. doi: 10.1002/jcph.1038.
3. Toda R, et al. Xenobiotica. 2017 Nov 2:1-15. doi: 10.1080/00498254.2017.1390625.
molnova catalog



related products
-
Tegoprazan
A novel potent, highly selective, competitive and orally active inhibitor of gastric H+/K+-ATPase with IC50 of ranging 0.29-0.52 uM porcine, canine and human H+/K+-ATPases in vitro.
-
Saviprazole
Saviprazole (Hoe-731), a proton pump inhibitor, is used potentially for treatment of gastric ulcer.
-
Lansoprazole
Lansoprazole is a proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid.